August 2026 Swing Trades Recap: $NBIS Gave It All Back

Disclosure: As of August 31, 2026 I hold positions in $MRNA and $TTWO in the account this recap covers. This is a record of trades already taken, not a trade idea; open positions can change at any time after publication without notice. Not personalized investment advice. See full disclaimer below.

The Month in One Paragraph

2 swings closed in August and 2 are still open. $NBIS was the whole month: I trimmed it twice at better than 17% and then gave all of it back after I accidentally closed the position and re-entered at a much higher cost. $ANF worked too and closed on the last day of the month for a small win, and $MRNA is the name I carried into September, along with a $TTWO starter I opened on the last day of the month. The read was right on all three, and the one big loss was self-inflicted.

Closed This Month

$NBIS

I went long $NBIS on August 12 on a 4.5-star EP setup at the open. Volume wasn't overwhelming but it kept grinding higher, so instead of taking the quick profit I let it run and kept it as a swing at a $230.68 average. It worked right away. I trimmed the first piece on August 14 at $271.05, which is +17.5% versus entry, and sold another 1/3 on August 17 at $271.50, or +17.7%.

Then I broke it. During that August 17 trim I accidentally closed the entire remaining swing and re-entered the same day, which reset my average entry to $271.80. That's roughly where the stock topped out. It was marked at $255.26 on August 18, and on August 19 it broke down from around $228 to around $216 after the open, so I closed the whole thing there for a loss much bigger than everything the two trims had made.

The read was never the problem here and neither was the scaling. My own note that day was that my take-profits were sloppy and profit-driven instead of plan-driven, and that's fair, but the loss itself traces to one mis-click and then a decision to re-enter a position I had just closed. Buying back in at $271.80 to hold a swing I had entered at $230.68 was the actual mistake.

$ANF

I bought $ANF on August 26 after it gapped from around $115 to around $130 in the premarket and then broke out again after the open into the $151 to $152 area. My average entry was $144.18 and the plan was just to hold the breakout; there was no fundamental story behind it. It never extended much past that first day, and on August 31 it came back down near my entry and I closed it for a small win. Getting out green on a breakout that stopped working is a fine outcome, so no complaints on that one.

Adds and Trims

The only other scaling this month was $MRNA. I took it as an EP long at the open on August 19, took profit along the way as it ran from the low 120s toward 160 intraday, and kept roughly 1/4 of the size as the swing piece.

Still Open

$MRNA is the swing I carried out of August, and that leftover quarter sits at a $124.03 average. It was marked at $141.40 on August 31, so it's up about 14% versus cost. There's no fundamental thesis here, it's a momentum hold, so what invalidates it is simple: the trend rolling over and the name giving up the strength that got me in.

$TTWO is the other open name, and it's brand new. I went long on August 31 at $219.97, sized as a starter. It went on the books in the last hours of the month, so there's nothing to grade yet; it's here because it was open when August closed.

Carrying Into Next Month

I'm going into September with $MRNA still on and the new $TTWO starter next to it. The read stays alive only as long as the trend does, and if that breaks, the reason I own it is gone. The other thing I'm carrying is the $NBIS lesson, because my process on the way up was fine and the damage came from the order screen, not from the chart.

Related Reading: Why I Closed My $PLTR Calls After the $122.50 Break and Why I Took Profit on My $VRT Call at the Prior High

Howard is a full-time trader based in New Jersey with 13 years of experience across Forex, crypto, equities, and futures. He started Position Note to document his trades and analysis in public. All positions are disclosed. Nothing here is personalized investment advice.